Treatment of pediatric acute lymphoblastic leukemia

Details for Australian Patent Application No. 2009313039 (hide)

Owner MICROMET AG

Inventors Zugmaier, Gerhard

Agent Griffith Hack

Pub. Number AU-A-2009313039

PCT Pub. Number WO2010/052013

Priority 61/183,291 02.06.09 US; 61/221,269 29.06.09 US; 61/112,323 07.11.08 US

Filing date 6 November 2009

Wipo publication date 14 May 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/052013 Priority application(s): WO2010/052013

20 September 2012 Alteration of Name

  The name of the applicant has been altered to Amgen Research (Munich) GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313040-Treatment of acute lymphoblastic leukemia

2009313037-Novel process for the preparation of amino acid derivatives